Description
Tema pioneers an innovative thematic ETF platform, dedicated to ETF infrastructure and distinctive strategies led by seasoned investment experts. Their approach emphasizes long-term, burgeoning themes, employing a meticulous investment process blending bottom-up security selection with systematic portfolio construction.
Platform Details
Number of ETFs
6
Total ETF Assets
$227.38M
Disclosure

Cash Payments: We may receive payment from companies or organizations for featuring their securities or products in our content.

Affiliate Relationships: We may have affiliate relationships with companies mentioned in our content. This means that if you click on a link or use a referral code and make a purchase, we may earn a commission or receive other benefits.

Sponsorships: We may enter into sponsorship agreements with companies or organizations related to the financial industry. These sponsorships could involve financial compensation.

Important Points to Consider:

Diligence: Please conduct your research and due diligence before making any investment decisions based on the information presented in our content. Our opinions are our own and should not be considered as financial or investment advice.

Regulatory Compliance: We strive to comply with all relevant laws and regulations governing the creation and dissemination of financial content.

Not an Endorsement: Any mention of specific securities, products, or investments should not be construed as an endorsement or recommendation. It is essential to consider your individual financial goals and circumstances.

Current Offerings

CANC

Tema Oncology ETF
$26.00
-3.33[-11.36%]
What is CANC?
The Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The Adviser will use internal research and analysis based on company disclosure (such as 10-K filings, company presentations, capital markets day presentations) and other publicly available sources (e.g., sell-side research, biotechnology industry publications etc.) to make this assessment. Example companies include large pharmaceutical firms, diagnostic focused businesses with products used to diagnose cancer (such as liquid biopsies or cancer genomic screening), medical device companies focused on cancer treatment, and healthcare service providers with a specific strategic focus on helping treat and manage cancer.
Monthly Flows
0.26 M
Average Volume
391
Shares Outstanding
0.7 M
Top Holdings:
Get Details

RSHO

Tema American Reshoring ETF
$36.68
0[0.00%]
What is RSHO?
The Tema American Reshoring ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, common and preferred stocks of publicly listed companies domiciled in the United States that are directly or indirectly economically tied to the rebuilding, bringing back of overseas economic activity, and revitalization of the American (i.e., United States) industrial base (reshoring companies). Reshoring companies are companies that have publicly announced, indicated in public filings or otherwise communicated major initiatives to reshore jobs, manufacturing and other business activities to the U.S. including announcements of new factory or production facility openings in the U.S., expansions in the U.S. that aim to create several thousand jobs and/or plans for multi-billion-dollar U.S. projects involving reshoring.
Monthly Flows
0.00 M
Average Volume
3,048
Shares Outstanding
0.4 M
Top Holdings:
Get Details

LUX

Tema Luxury ETF
$22.71
0[0.00%]
What is LUX?
The Tema Luxury ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in common and preferred stocks of publicly listed companies that are contained within a recognized global luxury index, such as the S&P 500 Global Luxury Index or other comparable luxury index. Companies in the luxury industry can encompass the following types of providers of luxury goods and services: brand owners, manufacturers, distributors, wholesalers, retailers, technology providers, and online platforms. Products or services deemed of relevance to the luxury industry can include the following categories of luxury goods and services: apparel, leather goods, jewelry, watches, shoes, beauty, eyewear, automobiles, boats, aircrafts, hotels and buildings, food and beverage, furniture, homeware, and art. In this context luxury goods and services are defined as those having higher quality and craftmanship than the average product and service available to consumers and consequently sold at a premium price point and marketed to relatively high net worth consumers.
Monthly Flows
0.00 M
Average Volume
1,539
Shares Outstanding
0.3 M
Top Holdings:
Get Details

TOLL

Tema Monopolies and Oligopolies ETF
$32.31
0[0.00%]
What is TOLL?
The Tema Monopolies and Oligopolies ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in domestic and foreign, common and preferred stocks of publicly listed companies where the Herfindahl Hirschman (HHI) index of the market of operation representing more than 50% of the companys revenue is above 2,500. HHI index is a widely used and commonly accepted measure of market concentration. HHI is calculated by squaring the market shares of each competing firm and then summing the numbers. The HHI takes into account the relative size distribution of the firms in a market. It approaches zero when a market is occupied by a large number of firms of relatively equal size and reaches its maximum of 10,000 points when a market is controlled by a single firm.
Monthly Flows
0.00 M
Average Volume
704
Shares Outstanding
0.2 M
Top Holdings:
Get Details

ROYA

Tema Global Royalties ETF
$
What is ROYA?
The Global Royalties ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in domestic and foreign, common and preferred stocks of publicly listed companies that earn, in normal circumstances, at least 80% of their revenue from royalty income, royalty-related income and intellectual property income.
Monthly Flows
0.00 M
Average Volume
174
Shares Outstanding
0.2 M
Top Holdings:
Get Details

HRTS

Tema Cardiovascular and Metabolic ETF
$34.32
0.25[0.73%]
What is HRTS?
The investment seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases. Obesity is on the cusp of a revolution in therapeutics, while heart disease, the most common cause of death, is witnessing a renaissance of therapies driven by genetic insights and tools.
Monthly Flows
9.98 M
Average Volume
31,422
Shares Outstanding
1.2 M
Top Holdings:
Get Details